| 1. |
Malet-Martino M, Jolimaitre P, Martino R. The prodrugs of 5-fluorouracil[J]. Curr Med Chem Anticancer Agents, 2002, 2(2):267-310.
|
| 2. |
Yokoyama T, Hosoya Y, Aoki T, et al. Angina attack caused by 5-fluorouracil infusion——report of a case and review of the literature[J]. Gan To Kagaku Ryoho, 2002, 29(10):1805-1808.
|
| 3. |
廖昆侖, 蔡瑞卿, 胡小春, 等. Avastin聯合化療治療晚期腸癌患者的護理[J]. 中國實用護理雜志, 2011, 27(7):65-66.
|
| 4. |
朱康玲, 黃素萍. 表柔比星治療乳腺癌對心臟毒性反應的護理[J]. 解放軍護理雜志, 2004, 21(6):71.
|
| 5. |
劉冰潔, 李小平, 王建六, 等. 婦科惡性腫瘤化療期間發生心臟毒性反應30例臨床分析[J]. 中華婦產科雜志, 2011, 46(12):884-887.
|
| 6. |
王君艷, 劉景華, 王曉明. 恩度聯合NP方案化療非小細胞肺癌心臟毒性反應的觀察與護理[J]. 中國現代藥物應用, 2008, 2(17):105-106.
|
| 7. |
Dent RG, McGoll I. Letter:5-fluoracil and angina[J]. Lancet, 1975, 1(7902):347-348.
|
| 8. |
劉秀春, 亓建哲, 李文力, 等. 吡喃阿霉素與5-氟脲嘧啶聯合用藥引起的心臟毒性——附4例報道[J]. 腫瘤基礎與臨床, 2006, 19(3):255.
|
| 9. |
Wacker A, Lersch C, Scherpinski U, et al. High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients[J]. Oncology, 2003, 65(2):108-112.
|
| 10. |
陳國榮. 5-氟尿嘧啶的心臟毒性及防治進展[J]. 新鄉醫學院學報, 2011, 28(6):781-783.
|
| 11. |
Abou El Fadl MH, Bagai RK, Spiro TP, et al. 5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel[J]. Gastrointest Cancer Res, 2009, 3(4):167-170.
|
| 12. |
Talapatra K, Rajesh I, Rajesh B, et al. Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil[J]. J Cancer Res Ther, 2007, 3(3):169-171.
|
| 13. |
Tsavaris N, Kosmas C, Vadiaka M, et al. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy ——a survey of 427 patients[J]. Med Sci Monit, 2002, 8(6):PI51-PI57.
|
| 14. |
Sabri B, Ceyhun C, Nezih M, et al. A new perspective on cardiotoxicityof 5-fluorouracil[J]. Pharmacology, 2004, 50(3):113-118.
|